ABSTRACT This study was intended to establish the extent which amino acids (AAs) and glucose are net metabolized by the gastrointestinal tract (GIT) of ruminant sheep when intestinal protein supply is varied. Wether sheep (n ¼ 4, 33 6 2.0 kg) were fitted with catheters for measurement of net absorption by the mesenteric (MDV) and portal-drained (PDV) viscera and a catheter inserted into the duodenum for casein infusions. 2 ¼ 0.46-1.79 for MDV; P , 0.05, R 2 ¼ 0.6-1.58 for PDV) with casein infusion rate. Net absorption by the PDV accounted for ,100% of the additional supplies of leucine, valine, and isoleucine (0.6-0.66, P , 0.05) from casein infusion, whereas net absorption by the MDV accounted for 100% of the additional essential AA supply. Glucose absorption (negative) and utilization of arterial glucose supply by the GIT remained unchanged. There was a positive linear (P , 0.05) relation between transfer of plasma urea to the GIT and arterial urea concentration (MDV, P , 0.05, r ¼ 0. In ruminants, metabolism by the gastrointestinal tract (GIT) 4 represents the single largest metabolic fate of amino acids (AAs), glucose, and other energy substrates in the body. Depending upon the AA, the GIT metabolizes 5-100% of the AA supply disappearing from the small intestines, and 50-100% of intestinal disappearance of glucose (1-3). The nutritional importance of GIT metabolism is well known, yet there are still important aspects of GIT metabolism that remain largely unresolved. With regard to AA metabolism, it could be hypothesized that, at a minimum, net metabolism of essential AAs by the GIT occurs at a fixed rate and an amount relative to their compositions in the endogenous proteins lost from the GIT. Thus, once this ''service cost'' is satisfied, absorption of AAs across the GIT should approximate to 100% of their additional intestinal supplies. Current information suggests that this may not be the case, however, particularly with regard to certain nonessential AAs (4-9).
In ruminants, metabolism by the gastrointestinal tract (GIT) 4 represents the single largest metabolic fate of amino acids (AAs), glucose, and other energy substrates in the body. Depending upon the AA, the GIT metabolizes 5-100% of the AA supply disappearing from the small intestines, and 50-100% of intestinal disappearance of glucose (1-3). The nutritional importance of GIT metabolism is well known, yet there are still important aspects of GIT metabolism that remain largely unresolved. With regard to AA metabolism, it could be hypothesized that, at a minimum, net metabolism of essential AAs by the GIT occurs at a fixed rate and an amount relative to their compositions in the endogenous proteins lost from the GIT. Thus, once this ''service cost'' is satisfied, absorption of AAs across the GIT should approximate to 100% of their additional intestinal supplies. Current information suggests that this may not be the case, however, particularly with regard to certain nonessential AAs (4) (5) (6) (7) (8) (9) .
Net absorption of AAs by the small intestines of ruminants has been determined from the product of net arteriovenous difference and blood flow measurements across the mesentericdrained viscera (MDV). Most often, however, net metabolism by the whole GIT is determined from measurements across the portal-drained viscera (PDV), which represents the sum of MDV plus rumen and hind-gut metabolism. This measure accounts for intestinal metabolism as well as that occurring by the rumen and hind-gut tissues, the latter of which derive AAs almost exclusively from the arterial blood supply (1) . Although this arterial use of AAs by the PDV is considered a consequence of GIT metabolism, this arterial use of AAs represents potential competition with peripheral tissues (e.g., muscle, mammary gland). Based on PDV net flux measurements (dairy cows: (3,4,10); sheep: (1)) net recovery of infused casein, or free AAs, or absorbed essential AAs, is generally found to be lowest for the branched-chain AAs (BCAA: leucine, valine and isoleucine; 10-62%), followed variously by methionine (33-69%), histidine (39-92%), phenylalanine (36-96%), lysine (30-66%), tryptophan (31-88%) and threonine (41-63%). By contrast, intestinal supplies of the nonessential AAs glutamine and glutamate have been found to be almost completely metabolized by the GIT, even when the supplies of these AAs are increased (4) (5) (6) (7) (8) (9) . These studies examined PDV nutrient use in response to only one level of protein, AAs or feed intake, and so it has not been possible to establish response relations of intestinal supply and net absorption of individual AAs. In consequence, it is not known whether GIT metabolism occurs at a fixed or variable rate for individual AAs, and nor is it known whether this GIT metabolism ultimately leads to differential supplies of AAs to the liver, and beyond to peripheral tissues, for anabolic use.
The aim of this study is to answer 2 central questions regarding AA utilization by the ruminant GIT: 1) are certain AAs preferentially utilized, and 2) are certain AAs metabolized at fixed or variable rates relative to changes in their intestinal supply? A secondary aim relates to observations that the GIT of ruminants net metabolizes the intestinal supply of glucose (5, 11) . For this reason, the net balance of glucose across the GIT is often negative. In this respect, a goal was to determine whether glucose utilization is reduced or unaffected by changes in the intestinal supply and GIT utilization of AAs.
MATERIALS AND METHODS
Sheep and surgery. The experimental protocol was approved by the Institutional Animal Care and Use Committee at the University of Maryland. Four mixed-breed (Polypay 3 Dorsett, 33 6 2.0 kg body weight (BW), 5 to 6-mo-old) wether lambs were prepared under general anesthesia with vascular catheters (Silastic, 0.64 mm i.d., 1.19 mm o.d.) placed in the distal and proximal mesenteric vein, the hepatic portal vein, and a femoral artery. The tip of the proximal mesenteric vein blood sampling catheter was positioned ;5 cm from the ileo-cecal vein junction at the most proximal point where the venous drainage from proximal small intestine enters the mesenteric arcade (see 12) . The tip of the distal mesenteric vein catheter was positioned ;30 cm upstream of the proximal catheter for infusion of the blood flow marker para-aminohippuric acid (PAH). A catheter (polyvinyl chloride, 2.4 mm i.d. 3 4.0 mm o.d.) was also inserted into the proximal duodenum, the tip ;10 cm from the pylorus, for infusion of casein. From 2 wk postsurgery, feed ( Table 1 ) was delivered in equal portions every 2 h via an automatic feeder. Sheep were fed to 2 times energy maintenance intake (10.9 MJ/d, ;80 g dry matter/kg BW 0.75 ) a pelleted ration that was adequate in energy (calculated 10.2 MJ metabolizable energy/kg dry matter) but which was low in protein (10.4% crude protein, dry matter) and provided only ;60% of the metabolizable protein intake (;75 g/d) required to support 300 g of gain per day (13).
Casein infusion. Sheep were placed in individual metabolic crates equipped with automatic feeders and fresh water was provided daily. H 3 ]leucine (30 mg/h) was infused into the duodenum along with water or casein infusions. Over the final 4 h, blood samples were continuously withdrawn (5 mL/h) over 1-h periods from the artery, proximal mesenteric vein, and portal vein by peristaltic pump and collected into sealed syringes submerged in an ice bath. Each syringe was mixed by gentle hand rolling, and the plasma separated by centrifugation (1000 3 g for 15 min at 48C).
Plasma amino acid and urea concentration. These were determined by isotope dilution with gas chromatography-mass spectrometry (GC-MS) as previously described (14) . To a known weight (0.5 g) of fresh plasma was added an equal known weight of a solution containing 0. PAH concentration. Plasma concentrations of PAH were determined in duplicate using 0.25 g plasma and employing gravimetric procedures (16) .
Calculation of net fluxes of amino acids. Net absorption or removal of an AA by the mesenteric (MDV; mostly small intestines) and portal (PDV; whole GIT) drained viscera was calculated as the product of plasma flow (F; [kg/(kg BW Á h)]) and plasma venoarterial concentration difference (mmol/kg plasma) as appropriate. The incremental recovery by the MDV and PDV of individual AAs infused as casein into the duodenum was determined from the slope of the regression of net flux rate against duodenal casein-AA infusion rate [mmol/(kg BW Á h]. The intestinal digestibility of casein was assumed to be 100% (17) .
Calculation of leucine fluxes. Rate leucine of appearance (Leu R a ) was calculated from arterial plasma leucine enrichment (E A ) when the leucine tracer was infused into the jugular vein ([ 
where IR is the rate of [ 2 H 3 ]leucine infusion into the duodenum. Calculation of glucose utilization. Net removal of plasma glucose by the MDV and PDV was calculated as above for AAs. Glucose rate of appearance (gluconeogenesis, glucose recycling, and absorption) was calculated as described for Leu R a . First-pass arterial utilization of glucose by the MDV and PDV was calculated as:
where E is the enrichment (APE) of [ Statistical analysis. For all data, ANOVA assumptions were checked prior to analysis. Data were analyzed by 3-way ANOVA for a 4 3 4 Latin square design using the MIXED procedure of SAS (version 8.0, SAS Institute), in which the infusion level was the fixed effect and sheep and experimental period are random effects. The following linear mixed model was used:
where Y ijk is the observed value for the k th sheep, the j th period and the i th treatment, m is the grand mean, T i is the treatment effect for the i th treatment, R j is the period effect for the j th period, C k is the sheep effect for the k th sheep, and e ijk is the random error associated with Y ijk . When a significant treatment effect was detected, means were compared using Tukey-Kramer multiple comparison test. Backward stepwise regression was performed in which a third-order model was tried first, and, if not significant, the analysis was repeated with a lower-order model until significance was reached. The 95% CI were calculated for the slopes of the regression equation. Significance of differences between first-pass utilization and net absorption was assessed by Student's t test. Data are presented as least square means 6 SEM and differences were considered significant at P # 0.05.
RESULTS

Sheep
Plasma concentrations. Casein infusion significantly increased (P , 0.05) arterial concentrations ( Table 2 ) of the BCAA, methionine, phenylalanine, and proline, whereas glycine concentration decreased (P , 0.05). Plasma urea also increased (P , 0.001) with level of casein infusion, with values doubling between the control and the 105 g/d casein infusion level.
MDV net fluxes. Casein infusion (P , 0.05) increased the net appearance in the MDV of all the essential AA (Table 3) , except for tryptophan. Among the nonessential AAs, the net 
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RUMINANT GASTROINTESTINAL USE OF AMINO ACIDS appearances of only alanine (P , 0.05) and proline (P , 0.001) increased with casein infusion level. The incremental efficiency of absorption (D net absorption ‚ D casein-AA infusion) was computed based on the slope of regressing net AA absorption against the casein-AA infusion rate for that AA (see Fig. 1 ). The 95% CI were generated to test for unity, i.e., a slope of 1 5 100% recovery of the infused AA. Net MDV absorption ( Table 4 ) of all essential and nonessential AAs, except for glutamate and glutamine, was linearly (P , 0.05) related to their casein-AA infusion rates. The incremental efficiency of absorption across the MDV fell within a narrow range (0.87-1.05) for all essential AAs, excluding tryptophan. For the nonessential AAs, values ranged from 0.46 for aspartate to 1.79 for alanine. Because of the wide 95% CI associated with each AA measurement, however, none of the slopes were significantly different from unity for the MDV (small intestines). Thus, recovery of AA across the MDV was not different from 100%.
PDV net fluxes. Net PDV absorption (Table 5 ) of leucine, isoleucine, methionine, phenylalanine, alanine, proline, and aspartate increased (P , 0.05) in a linear relation with their casein-AA infusion rates. Based on the regression slopes, the incremental efficiency of absorption (Table 6 ) across the PDV ranged from 0.60 for valine and isoleucine to 0.93 for phenylalanine, with a high of 1.58 for alanine. For the BCAA, the upper confidence limits were ,1 (P , 0.05), indicating that ,100% of the additional supplies of these AAs were recovered in blood by the PDV.
For the MDV and PDV, net removal of urea from plasma was not affected by casein infusion although, numerically, the values were higher. The correlation of urea removal with plasma urea concentration was significant for the MDV (P 5 0.0379, r 5 0.90) and PDV (P 5 0.0124, r 5 0.93).
Leucine metabolism. Rate of casein infusion increased (P , 0.01) systemic and whole body leucine R a ( Table 7) . As a proportion of whole body leucine R a , the MDV accounted for 0.16 (6 0.059), whereas casein infusion increased the proportion (0.33-0.60 6 0.060, P , 0.033) of whole body leucine R a partition to the PDV. Although net absorption of leucine Tables 5  and 6 for linear regression analysis).
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by the PDV increased with casein infusion, there was also increased (P , 0.05) first-pass arterial utilization of leucine by the PDV. For the MDV, net absorption of leucine increased with casein infusion, but there was no change in the rate of first-pass arterial utilization. Fractional first-pass intestinal utilization was computed from PDV, rather than MDV, flux measurements to avoid introduction of errors due to site of luminal tracer infusion and location of the downstream MDV sampling catheter. Fractional first-pass intestinal utilization of leucine was higher (Student's t test, P , 0.05) than fractional first-pass arterial utilization, but neither was altered by casein infusion. Glucose metabolism. Plasma glucose concentration increased (P , 0.05) with the casein infusion rate ( Table 8) , whereas plasma glucose R a remained unchanged. The relation of glucose R a and casein infusion rate was linear (P , 0.05, R 2 5 0.76), with daily glucose R a increasing by 0.188 g glucose/g casein infused. Intestinal casein infusion did not alter the amount and proportion of whole body glucose R a partitioned to the PDV. The PDV accounted for ;0.38 of whole body glucose R a , whereas the MDV accounted for a smaller but increasing (0.11-0.24) proportion in response to casein infusion. Because of the higher rates of first-pass arterial utilization of plasma glucose, the net balances of glucose across the PDV and MDV were negative (i.e., arterial utilization . net absorption) and these were not significantly affected by casein infusion. With first-pass arterial utilization of glucose by the PDV (Student's t test, P , 0.001) and MDV (Student's t test, P , 0.0011), both exceeded net glucose removal, indicating that glucose was absorbed from the small intestines only to be removed from the blood on second pass.
DISCUSSION
Despite the numerous studies in the literature, there is a lack of information in ruminants and other farm species regarding the patterns of AA utilized by the GITs, and whether this pattern of use fluctuates or remains unchanged with intestinal protein supply. In part, the availability of such information has been limited by analytical and technical constraints of existing methodologies. Therefore, to address the questions we posed, the methods we used for measuring blood flow and substrate concentrations needed to be sufficiently accurate and sensitive for detection of biologically and statistically significant changes in the flux of AAs, urea, and glucose by the GIT. Herein, gravimetric (i.e., weighing) procedures and isotope dilution with GC-MS were used to quantify plasma AAs, urea, and glucose concentrations. Based on the isotope-dilution technique, the coefficient of determination was 0.56-3.93% for individual AAs, 0.12% for urea, and 0.33% for glucose. By contrast, conventional AA analyzers may reach a precision of only 1-4% (18) , and this variance is further propagated when measurements of both arterial and venous concentrations are combined for detecting often small (2-15 mmol/L) arteriovenous differences across tissue beds (19) , such as in the present study.
It was also important that our measurements of GIT metabolism were made over a wide range of intestinal protein supplies, spanning from marginal to above the estimated metabolizable protein requirements for maintenance and growth of sheep with this body weight. This was achieved by infusing casein into the duodenum at 4 levels (0, 35, 70, and 105 g/d). The highest level of protein supply was predicted to raise total protein supply (diet 1 casein infusion) to 110% of the metabolizable protein supply required to support gain of 300 g/d for sheep of this size (13). Furthermore, to acquire a more representative estimate of the efficiency of AA absorption, net fluxes for each AA were plotted against their respective casein-AA infusion rates ( Fig. 1 and Tables 5 and 6 ). Regression slopes were analogous to the net efficiency of absorption above the basal level of protein intake in this study. CI (95%) were then computed from the slope relationships, and tests against unity (i.e., 100%) were performed for each AA. We highlight 3 observations from the slopes of the regression analysis. First, the net absorption data for each essential AA best fit a linear relation (P , 0.005; Fig. 1 and Tables 5 and 6 ) in response to casein infusion. We had hypothesized that, because the level of metabolizable protein intake (;75 g/d) of the basal ration was low relative to growth requirements, net AA requirements of the GIT may not have been met and, in consequence, net absorption would not increase until perhaps Fig. 1 ), there appears to be no indication of an inflection in net absorption, but this will need to be further confirmed at lower protein intakes and with a larger number of observations. Second, the 95% CI of the slopes indicated that essential AA absorption by the MDV (small intestines) was effectively 100% (i.e., slope ¼ 1) whereas absorption of the BCAA by the PDV was significantly ,100% (i.e., slope ,1). Also approaching significance were the slopes for threonine (slope 0.75, 95% CI 0.36-1.10) and lysine (slope 0.78, 95% CI 0.55-1.05) for the PDV. We interpret these data as a demonstration that the small intestines (MDV) were in net balance with respect to essential AA utilization, irrespective of the rate of intestinal protein supplies above the maintenance requirement. The net efficiency of absorption of the BCAA by the PDV was ,100% (slope ranges: 0.60-0.66, 95% CI 0.31-0.91) across the protein infusion levels with, in consequence, greater net metabolism (e.g., lost as protein into the GIT or catabolized) of the BCAA as intestinal protein supply increased. In fact, for leucine, as representative of the BCAA, the majority of the increased use by the GIT occurred from the arterial blood supply (Table 7) , mainly by the non-MDV tissues (i.e., rumen and hind gut). 
